跳至主要内容
临床试验/NCT00181662
NCT00181662已完成不适用

Evaluation of Naturally Occurring Inhibitors of UDP-glucuronyltransferase on the Oral Bioavailability of Curcumin in Normal Healthy Volunteers

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2005年8月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
6
试验地点
2
主要终点
Curcumin pharmacology

研究概览

简要总结

This study looks to describe the pharmacokinetics of curcumin delivered as a single oral dose in healthy female volunteers. The impact of piperine and silybin on the pharmacokinetics of curcumin is also studied.

详细描述

Healthy volunteers are seen on three separate visits and receive 4 gm of curcumin as a single oral dose either alone or with piperine or with silybin. Serial timed blood draws then are collected for pharmacokinetic analysis.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Healthy volunteer
  • On no medications except for birth control pills
  • Signed informed consent

排除标准

  • Comorbid disease

结局指标

主要结局

Curcumin pharmacology

次要结局

  • Interactions between silybin and curcumin
  • Interactions between piperine and curcumin

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Laura Sullivan

Study Official

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验